| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | F DE Nuccio | |
| D M Toraldo | |||
| E Scoditti | |||
| M DE Benedetto | |||
| P2860 | cites work | Coagulability in obstructive sleep apnea | Q26830210 |
| Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis | Q28279053 | ||
| Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials | Q30954736 | ||
| Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease | Q33194719 | ||
| Sleep-disordered breathing and mortality: a prospective cohort study | Q33494520 | ||
| Independent association between obstructive sleep apnea and subclinical coronary artery disease | Q33700621 | ||
| Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea | Q33748662 | ||
| Snoring and the Risk of Obstructive Sleep Apnea in Patients with Pulmonary Embolism | Q34021885 | ||
| Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study | Q34276124 | ||
| Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients | Q35258706 | ||
| Mechanisms of apnea | Q36189456 | ||
| Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities | Q36696149 | ||
| Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. | Q36891111 | ||
| Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. | Q36891117 | ||
| Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. | Q37186987 | ||
| Oxidative stress--a unifying paradigm in obstructive sleep apnea and comorbidities | Q37358633 | ||
| Inflammatory cardiovascular risk markers in obstructive sleep apnoea syndrome | Q37370316 | ||
| Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link | Q37502404 | ||
| Emerging from the shadows: a possible link between sleep apnea and cancer | Q37649888 | ||
| Oxygen sensing, homeostasis, and disease | Q37914865 | ||
| Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis | Q38053120 | ||
| Obstructive sleep apnoea, insulin resistance and adipocytokines | Q38243022 | ||
| Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain | Q38243066 | ||
| Plasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophages | Q38945452 | ||
| Influence of intermittent hypoxia on the signal transduction pathways to inflammatory response and circadian clock regulation. | Q39823512 | ||
| Update in sleep medicine 2013. | Q43464268 | ||
| Patients with venous thromboembolism appear to have higher prevalence of obstructive sleep apnea than the general population | Q44038649 | ||
| Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study | Q44651031 | ||
| Association of obstructive sleep apnoea with subclinical coronary atherosclerosis. | Q45999404 | ||
| Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study | Q46650854 | ||
| Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study | Q46688016 | ||
| Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea | Q46853105 | ||
| Sleep-related intermittent hypoxemia and glucose intolerance: a community-based study | Q48034681 | ||
| Cardiovascular morbidity and obstructive sleep apnea | Q48100719 | ||
| Profile of circulating cytokines: impact of OSA, obesity and acute cardiovascular events. | Q48187587 | ||
| Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis | Q48218459 | ||
| Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study | Q48258568 | ||
| Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea | Q48266496 | ||
| Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability | Q48377414 | ||
| Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea | Q48395056 | ||
| Short-term continuous positive airway pressure therapy reverses the pathological influence of obstructive sleep apnea on blood rheology parameters | Q48405438 | ||
| Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea | Q48422732 | ||
| Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea | Q48438000 | ||
| Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome | Q48464536 | ||
| Elevated plasminogen activator inhibitor 1 in sleep apnea and its relation to the metabolic syndrome: an investigation in 2 different study samples | Q48464645 | ||
| Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure | Q48507311 | ||
| Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome | Q48528105 | ||
| Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk | Q48544900 | ||
| Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats | Q48547568 | ||
| Is venous thromboembolism more frequent in patients with obstructive sleep apnea syndrome? | Q48578949 | ||
| The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. | Q48593429 | ||
| Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure | Q48643458 | ||
| Plasminogen activator inhibitor-I (PAI-I) polymorphisms in patients with obstructive sleep apnoea | Q48666407 | ||
| Platelet Function and Fibrinolytic Activity in Hypertensive and Normotensive Sleep Apnea Patients | Q48823182 | ||
| ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence a | Q51809161 | ||
| Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1 | Q83275264 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P433 | issue | 2 | |
| P921 | main subject | hypoxia | Q105688 |
| obstructive sleep apnea | Q16606552 | ||
| sleep-wake disorder | Q54972453 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 69-74 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Acta Otorhinolaryngologica Italica | Q2532736 |
| P1476 | title | Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption | |
| P478 | volume | 35 |
| Q37652581 | A comparative study on oxidative stress role in nasal breathing impairment and obstructive sleep apnoea syndrome |
| Q47639493 | Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure |
| Q87866404 | Antero-cervical thermophysiological characterization of obstructive sleep apnea patients |
| Q36682454 | Association between Plaque Score of the Carotid Artery and the Severity of Sleep Apnea Syndrome in Patients with Chronic Kidney Disease |
| Q52577399 | Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression. |
| Q39405764 | Cost-effectiveness strategies in OSAS management: a short review |
| Q59808495 | Increased Level of Angiopoietin Like Proteins 4 and 8 in People With Sleep Apnea |
| Q58804247 | Olfactory evaluation in obstructive sleep apnoea patients |
| Q90282093 | Periodontal disease, sleep duration, and white blood cell markers in the 2009 to 2014 National Health and Nutrition Examination Surveys |
| Q91615108 | Serum S100A12 and S100B proteins are independent predictors of the presence and severity of obstructive sleep apnea |
| Q37652575 | The role of masseter muscle EMG during DISE to predict the effectiveness of MAD: preliminary results |
Search more.